Yüklüyor......
Immune checkpoint inhibitors and small cell lung cancer: what’s new?
Despite extensive research no meaningful progress in systemic treatment of small cell lung cancer (SCLC) has been made in the past decades. Earlier attempts with immunotherapy including interferon and vaccination approaches had limited success. High mutational load, smoking history and potentially a...
Kaydedildi:
| Yayımlandı: | J Thorac Dis |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
AME Publishing Company
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5994505/ https://ncbi.nlm.nih.gov/pubmed/29953115 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.01.113 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|